North America Blood Collection Devices Market

The North America blood collection devices market is expected to grow from US$ 3,688.19 million in 2022 to US$ 5,950.62 million by 2030. It is estimated to grow at a CAGR of 6.2% from 2022 to 2030.   

Increase in Prevalence of Cancer Worldwide Fuels North America Blood Collection Devices Market

Healthcare facilities across the globe are observing a substantial increase in the prevalence of cancer. According to the National Cancer Institute, cancer is increasingly becoming a global health issue. In 2020, there were 19.3 million new cancer cases, resulting in approximately 10 million cancer-related deaths worldwide. The World Health Organization estimated that, by 2040, there could be 28.9 million new cancer cases globally and ∼16.2 million cancer-related deaths yearly.

The most common method for a blood test for cancer is a liquid biopsy; this method is used for diagnosing non-small cell lung cancer (NSCLC) and screening other types of cancers such as breast, colorectal, prostate, gastrointestinal, and ovarian. As a result, blood collection tubes contribute to the organization's strategy for the early detection of cancer, allowing for quick treatment and enhancing cancer patients' survival rates. Thus, the increasing prevalence of cancer drives the North America blood collection devices market.

North America Blood Collection Devices Market Overview

The North America blood collection devices market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American blood collection devices market in 2022. A rise in the demand for blood collection devices for the diagnostics of COVID-19, increasing incidence of chronic kidney diseases, and high R&D spending by medical device companies and grants provided by governments for research institutes to develop new blood study-related equipment are some of the prominent factors propelling the market growth.

North America

Blood Collection Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Blood Collection Devices Strategic Insights

Strategic insights for the North America Blood Collection Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Blood Collection Devices Report Scope

North America Blood Collection Devices Regional Insights

The geographic scope of the North America Blood Collection Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Blood Collection Devices Market Segmentation

The North America blood collection devices market is segmented into product type, methods, end user, and country.

Based on product type, the North America blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the North America blood collection devices market in 2022.

In terms of methods, the North America blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the North America blood collection devices market in 2022.

By end user, the North America blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the North America blood collection devices market in 2022.

Based on country, the North America blood collection devices market is segmented into the US, Canada, and Mexico. The US dominated North America blood collection devices market in 2022.   

Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH are some of the leading companies operating in the North America blood collection devices market.